Menu
GeneBe

ECD

ecdysoneless cell cycle regulator

Basic information

Region (hg38): 10:73130154-73169055

Links

ENSG00000122882NCBI:11319OMIM:616464HGNC:17029Uniprot:O95905AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ECD gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ECD gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
1
clinvar
4
missense
24
clinvar
1
clinvar
25
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 24 5 1

Variants in ECD

This is a list of pathogenic ClinVar variants found in the ECD region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-73130719-G-C not specified Uncertain significance (May 03, 2023)2524005
10-73130720-A-C not specified Uncertain significance (Aug 01, 2022)2304300
10-73130845-C-T not specified Uncertain significance (Sep 15, 2021)2316279
10-73130879-G-C not specified Uncertain significance (Dec 21, 2022)2338660
10-73130895-C-A not specified Uncertain significance (Oct 27, 2023)3202761
10-73134727-G-T not specified Uncertain significance (Jul 14, 2021)2237198
10-73134731-A-G not specified Uncertain significance (May 23, 2023)2550192
10-73134746-A-C not specified Uncertain significance (Nov 09, 2023)3086888
10-73134822-T-C Likely benign (Jul 16, 2018)739473
10-73136897-T-G not specified Uncertain significance (Sep 30, 2021)2401833
10-73138054-G-A not specified Uncertain significance (Aug 08, 2023)2617357
10-73139347-T-C not specified Uncertain significance (Dec 06, 2021)2265292
10-73139410-G-A Benign (Dec 31, 2019)780140
10-73139424-A-G not specified Likely benign (Feb 03, 2022)2229504
10-73139428-T-G not specified Uncertain significance (Dec 26, 2023)3086887
10-73139444-T-A not specified Uncertain significance (Oct 22, 2021)2256749
10-73139653-T-C Likely benign (Jul 06, 2018)713463
10-73139676-T-C not specified Uncertain significance (Apr 04, 2023)2554439
10-73148331-G-A not specified Uncertain significance (Oct 12, 2021)2213159
10-73148376-T-G not specified Uncertain significance (Oct 12, 2021)2254817
10-73152312-T-C not specified Uncertain significance (Sep 01, 2021)3086890
10-73152360-C-T not specified Uncertain significance (Feb 15, 2023)2463355
10-73152364-G-A not specified Uncertain significance (Jan 08, 2024)2399961
10-73152364-G-C not specified Uncertain significance (Apr 09, 2024)3274379
10-73154259-T-C Likely benign (Sep 01, 2022)2640581

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ECDprotein_codingprotein_codingENST00000430082 1438901
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.34e-120.85512562001281257480.000509
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3853203400.9410.00001664435
Missense in Polyphen97120.910.802251619
Synonymous0.5461151230.9370.000006001268
Loss of Function1.882436.20.6630.00000212426

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007910.000789
Ashkenazi Jewish0.000.00
East Asian0.0005300.000489
Finnish0.0002340.000231
European (Non-Finnish)0.0007630.000747
Middle Eastern0.0005300.000489
South Asian0.0002330.000229
Other0.0005010.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulator of p53/TP53 stability and function. Inhibits MDM2-mediated degradation of p53/TP53 possibly by cooperating in part with TXNIP (PubMed:16849563, PubMed:23880345). May be involved transcriptional regulation. In vitro has intrinsic transactivation activity enhanced by EP300. May be a transcriptional activator required for the expression of glycolytic genes (PubMed:19919181, PubMed:9928932). Involved in regulation of cell cycle progression. Proposed to disrupt Rb-E2F binding leading to transcriptional activation of E2F proteins (PubMed:19640839). The cell cycle -regulating function may depend on its RUVBL1-mediated association with the R2TP complex (PubMed:26711270). May play a role in regulation of pre-mRNA splicing (PubMed:24722212). {ECO:0000269|PubMed:16849563, ECO:0000269|PubMed:19640839, ECO:0000269|PubMed:19919181, ECO:0000269|PubMed:23880345, ECO:0000269|PubMed:26711270, ECO:0000305|PubMed:24722212, ECO:0000305|PubMed:9928932}.;

Recessive Scores

pRec
0.131

Intolerance Scores

loftool
0.998
rvis_EVS
0.05
rvis_percentile_EVS
57.52

Haploinsufficiency Scores

pHI
0.189
hipred
N
hipred_score
0.144
ghis
0.535

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.857

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Ecd
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
regulation of glycolytic process;transcription by RNA polymerase II;mRNA processing;cell population proliferation;RNA splicing;positive regulation of transcription by RNA polymerase II;regulation of G1/S transition of mitotic cell cycle
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol
Molecular function
transcription coactivator activity;protein binding;histone acetyltransferase binding